• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Investigation of impact of childhood immune imprinting on birth year-specific risk of clinical infection during influenza A virus epi

tetano

Editor, Senior Moderator
J Infect Dis


. 2023 Jan 13;jiad009.
doi: 10.1093/infdis/jiad009. Online ahead of print.
Investigation of impact of childhood immune imprinting on birth year-specific risk of clinical infection during influenza A virus epidemics in Hong Kong


Tim K Tsang[SUP] 1 2 [/SUP], Katelyn M Gostic[SUP] 3 [/SUP], Sijie Chen[SUP] 1 [/SUP], Yifan Wang[SUP] 1 [/SUP], Philip Arevalo[SUP] 3 [/SUP], Eric H Y Lau[SUP] 1 2 [/SUP], Sarah Cobey[SUP] 3 [/SUP], Benjamin J Cowling[SUP] 1 2 [/SUP]



Affiliations

Abstract

Influenza imprinting reduces risks of influenza A virus clinical infection by 40-90% estimated from surveillance data in western countries. We analyzed surveillance data from 2010-2019 in Hong Kong. Based on the best model included HA group-level imprinting, we estimated that individuals imprinted to H1N1 or H2N2 had a 17% (95% CI: 3%, 28%) lower risk of H1N1 clinical infection, and individuals imprinted to H3N2 would have 12% (95% CI: -3%, 26%) lower risk of H3N2 clinical infection. These estimates were weaker than estimated in western countries. Identifying factors affecting imprinting protections is important for control policies and disease modeling.

Keywords: Influenza; imprinting protection; surveillance.
 
Back
Top Bottom